Final results from Carthera’s international phase I/II clinical trial in patients with recurrent glioblastoma have been published in Nature Communications.
Dose escalation was safe, and the device provided 90% BBB disruption in a larger volume around the treatment area.
Median overall survival was highest in the group that received chemotherapy before BBB disruption.
Alzheimer’s disease impacts 6 million Americans, but focused ultrasound could offer hope.
In this blog, the Foundation’s Director of Clinical Relationships provides an overview of the current state of research using focused ultrasound to address the disease.
The Access FUS internship provides educational and research opportunities to undergraduate students from underrepresented and underserved backgrounds. Apply by April 15.
The Foundation’s Global Internship Program enables students to conduct focused ultrasound research with esteemed mentors in the field. Apply by April 21.
The Foundation and G2G Consulting recently held a congressional briefing to raise awareness and funding for focused ultrasound research.
Physicians and a patient treated for neuropathic pain discussed how focused ultrasound is being used to treat brain tumors, psychiatric conditions, and pain.
Med Device Online recently published an article by Foundation Chairman Neal F. Kassell, MD, about focused ultrasound–induced blood-brain barrier opening.
The article discusses the use of the application for enhancing cancer immunotherapies and delivering drugs to the brain.